Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy

The pathogenesis of glaucoma is strongly associated with the occurrence of autoimmune-mediated loss of retinal ganglion cells (RGCs) and additionally, recent evidence shows that specific antibody-derived signature peptides are significantly differentially expressed in sera of primary-open angle glau...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmelter, Carsten, Fomo, Kristian Nzogang, Perumal, Natarajan, Manicam, Caroline, Bell, Katharina, Pfeiffer, Norbert, Grus, Franz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723090/
https://www.ncbi.nlm.nih.gov/pubmed/31443184
http://dx.doi.org/10.3390/jcm8081222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723090/
https://www.ncbi.nlm.nih.gov/pubmed/31443184
http://dx.doi.org/10.3390/jcm8081222

Ejemplares similares